LOX-1, a marker for atherosclerosis (2), results to be overexpressed in several types of cancer, suggesting its role at the interface of atherosclerosis, metabolic disease and cancer (3, 4, 6–8, 33). The gene discussed is OLR1; the disease is metabolic disease.